Effect of (+)-cyanidanol-3 on chronic active hepatitis: A double blind controlled trial

S. Bar-Meir, Z. Halpern, M. Gutman, Z. Shpirer, Mimi Baratz, D. Bass

Research output: Contribution to journalArticlepeer-review

Abstract

Forty patients with biopsy proven chronic active hepatitis were studied, 22 received (+)-cyanidanol-3 in a dose of 3 g daily and 18 placebo. Side effects related to cyanidanol were fever (four patients), haemolysis (one patient) and urticaria (one patient). All side effects subsided on discontinuation of the medication. Cyanidanol had an effect no better than placebo on symptoms, laboratory tests, and histological findings on liver biopsy.

Original languageEnglish
Pages (from-to)975-979
Number of pages5
JournalGut
Volume26
Issue number9
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Dive into the research topics of 'Effect of (+)-cyanidanol-3 on chronic active hepatitis: A double blind controlled trial'. Together they form a unique fingerprint.

Cite this